COMMUNIQUÉS West-GlobeNewswire

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/03/2026
WATERTOWN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
09/03/2026
WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' [...]
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
09/03/2026
Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria (CSU) in Second Half of 2026 Advancing SEP-479 (PTH1R Agonist) Toward [...]
Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update
09/03/2026
- Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium, and the first brain [...]
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026
09/03/2026
WOBURN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization of photodynamic [...]
Stereotaxis Reports 2025 Full Year Financial Results
09/03/2026
ST. LOUIS, March 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth [...]
Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
09/03/2026
CORAL GABLES, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and [...]
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
09/03/2026
- Transformative year for tau in AD: VY1706 clinical entry and VY7523 clinical data anticipated H2 2026 - - Validating brain-targeted capsids in humans: expect two I.V.-delivered neuro gene therapies to enter clinic H2 [...]
COVID mRNA Vaccines May Alter Gene Expression, according to Journal of American Physicians and Surgeons
09/03/2026
TUSCON, Ariz., March 09, 2026 (GLOBE NEWSWIRE) -- The mechanism of action of mRNA vaccines goes far beyond harnessing host cellular machinery to produce antigenic proteins to spur immunity, write Nicolas Hulscher , M.P. [...]
SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
09/03/2026
Advanced SAB -142 into registrational Phase 2b SAFEGUARD study with multiple patients dosed; enrollment ongoing and on track to complete enrollment by end of 2026 with topline data expected in 2H 2027 Reported Phase 1 [...]
Novonesis named a Great Employer to Work For in North Carolina
09/03/2026
Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- Novonesis , a global leader in biosolutions, has been named a 2026 Great Employer to Work for in North Carolina by Best Companies Group (BCG), marking the [...]
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
09/03/2026
Initial MGC026 (B7-H3 ADC) Phase 1 results in mid-2026 Initial MGC028 (ADAM9 ADC) Phase 1 results in second half of 2026 Lorigerlimab Phase 2 LINNET study update in mid-2026 IND submission for MGC030, a first-in-class [...]
Direct Meds GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors
09/03/2026
A 2026 industry overview of the Direct Meds telehealth platform, including its compounded GLP-1 medication access model, pricing structure, delivery formats, consultation process, pharmacy sourcing, and considerations [...]
Slim Force BHB Ketone Claims Evaluated: 2026 Consumer Research Report on SlimForce Ingredients, Ketogenic Supplement Positioning, and What Adults Should Verify Before Purchasing
09/03/2026
An informational 2026 consumer research report examining Slim Force exogenous ketone formulation, BHB salt research context, proprietary blend transparency, pricing disclosures, and verification considerations for [...]
CapsoVision to Participate in the 38th Annual ROTH Conference
09/03/2026
- Company to participate in a fireside chat and 1x1 investor meetings on March 23, 2026 - SARATOGA, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology [...]
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
09/03/2026
Webcast Scheduled for Monday, March 16 at 8:30 a.m. Eastern CHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated injectables contract development [...]
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
09/03/2026
Anniversary Milestone Highlights Expanded Manufacturing Capacity, Stronger Asia-Pacific Presence, and Measurable Contributions to Global Supply Chain Resilience FREMONT, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- One [...]
Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas
09/03/2026
HOUSTON, March 09, 2026 (GLOBE NEWSWIRE) -- Sherry Cummings, Chief Executive Officer of Gryphon Healthcare , has been named one of the 2026 Women to KNOW in Texas , a prestigious statewide honor recognizing women who [...]
AEON Biopharma Appoints John Bencich as Chief Financial Officer
09/03/2026
Veteran biotechnology leader with extensive capital markets experience joins AEON as Company advances lead asset through key regulatory milestones IRVINE, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc [...]

Pages